EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been ...
Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the ...
EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a ...
LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, ...
Explore the complexities of blastic plasmacytoid dendritic cell neoplasm, its challenges in diagnosis, and advancements in targeted therapies for better outcomes.
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback